Endothelial cells express NKG2D ligands and desensitize antitumor NK responses

Natural Killer (NK) cells confer protection from tumors and infections by releasing cytotoxic granules and pro-inflammatory cytokines upon recognition of diseased cells. The responsiveness of NK cells to acute stimulation is dynamically tuned by steady-state receptor-ligand interactions of an NK cel...

Full description

Bibliographic Details
Published in:	eLife
Main Authors:	Thornton W Thompson, Alexander Byungsuk Kim, P Jonathan Li, Jiaxi Wang, Benjamin T Jackson, Kristen Ting Hui Huang, Lily Zhang, David H Raulet
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2017-12-01
Subjects:	Natural killer cells endothelial cells NKG2D
Online Access:	https://elifesciences.org/articles/30881

Similar Items

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
by: Ana Stojanovic, et al.
Published: (2018-04-01)

Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease
by: Daniel Fernández-Soto, et al.
Published: (2024-02-01)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
by: Fabrizio Antonangeli, et al.
Published: (2017-11-01)

Improvement of NK Cell Cytotoxicity in Reconstituting NK Cells after Allogeneic Stem Cell Transplantation by Blocking NKG2A Checkpoint
by: Mohammed Taha, et al.
Published: (2023-10-01)

Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys
by: Peter B. Rupert, et al.
Published: (2024-04-01)

Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases
by: Nadia Guerra, et al.
Published: (2020-04-01)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
by: Jack G. Fisher, et al.
Published: (2022-11-01)

NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG promotes NK cell activation
by: Eva María García-Cuesta, et al.
Published: (2015-06-01)

Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions
by: Caterina Marangio, et al.
Published: (2025-05-01)

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D
by: Mohammad Diab, et al.
Published: (2020-07-01)

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
by: Reem Alkhayer, et al.
Published: (2023-05-01)

Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
by: Daniel Fallon, et al.
Published: (2024-12-01)

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
by: Marcel Costa-García, et al.
Published: (2019-04-01)

The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)

NKG2D and Its Ligands: “One for All, All for One”
by: Alessandra Zingoni, et al.
Published: (2018-03-01)

Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma
by: Shirin Tavakoli, et al.
Published: (2024-12-01)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01)

Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells
by: Haeryung Cho, et al.
Published: (2021-06-01)

Molecular bases for the regulation of NKG2D ligands in cancer
by: Leticia eHuergo-Zapico, et al.
Published: (2014-03-01)

Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D
by: Kevin J. Lopez, et al.
Published: (2023-11-01)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01)

NK cell education: Physiological and pathological influences
by: Philippe Rascle, et al.
Published: (2023-01-01)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
by: Peggy Riese, et al.
Published: (2020-06-01)

Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation
by: Kuang Youlin, et al.
Published: (2023-04-01)

KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors
by: Alice Mac Donald, et al.
Published: (2023-08-01)

Leveraging NKG2D Ligands in Immuno-Oncology
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)

Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A
by: N. A. Alekseeva, et al.
Published: (2024-09-01)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
by: Christina David, et al.
Published: (2023-06-01)

Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
by: Jordi Pfeifer Serrahima, et al.
Published: (2024-08-01)

Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells
by: Anne Kiefer, et al.
Published: (2024-01-01)

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
by: Niken M. Mahaweni, et al.
Published: (2018-06-01)

A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
by: Alessandra Zingoni, et al.
Published: (2020-03-01)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)

Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins
by: Miriam Aarsund, et al.
Published: (2022-09-01)

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway
by: Jingjing Pu, et al.
Published: (2024-01-01)

Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
by: Steven T. Cox, et al.
Published: (2018-06-01)

Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Jose Luis Rivas, et al.
Published: (2018-05-01)

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
by: Ece Canan Sayitoglu, et al.
Published: (2020-01-01)